You’re now viewing the transfusion website.
Visit:
Blood Donors
Patients
Research
Media Centre
Corporate
Careers
Red Cross
Print
Smaller text
Larger text
iTransfuse Online Learning
About us
Authors & editors
Dr Ben Saxon
Dr Beverleigh Quested
Dr Cindy Flores
Dr Clive Seed
Dr Kathryn Robinson
Dr Kenneth Nollet
Dr Keri Hughes
Dr Oi-Lin Lee
Dr Sandy Minck
Jenita Allen
Simon Benson
Tanya Raison
Tracey Spigiel
Medical Services
Contact us
Inventory & distribution
Feedback form
iTransfuse Online Learning Support
Site map
Australian Red Cross Blood Service
Search this site:
Blood products
Blood components
Red cells
Red cell additives
Platelets
Platelet additives
Apheresis platelet packs
Fresh frozen plasma
Apheresis plasma packs
Cryodepleted plasma
Cryoprecipitate
Whole blood
Whole blood anticoagulants
Modified blood components
CMV seronegative
CMV tested components
Frozen Red cells
Irradiation
Indications for irradiated components
Paediatric size
Phenotyped
Washed
FAQ: Leucodepletion
Fractionated plasma products
Albumin
Factor concentrates
Immunoglobulins
Intravenous immunoglobulin
IVIg calculator
Component labelling
Label modifier texts
Donor selection
Collection & testing
Bacterial contamination screening
Screening platelets for contamination
Pathogen inactivation
FAQ: NAT for HBV
Therapeutic venesection
Blood groups
Blood group phenotypes
Rhesus phenotypes
Inheritance patterns
Antigens & antibodies
Red cell antigens
Platelet antigens
Neutrophil antigens
Leucocyte antigens
Compatibility
Red cell compatibility
Platelet compatibility
Plasma compatibility
Storage & handling
Transport of blood
Validated transport times
Maintenance of storage devices
Transfusion practice
Overview of transfusion medicine
Does your patient need a transfusion?
Minimise the need for a transfusion
Transfusion alternatives
Plasma replacement fluids
Indications for recombinant products
Checklist for prescribing clinicians
Transfusion committees
How to start a HTC
Clinical governance
Appropriate transfusion practices
Clinical use of blood components
Use of red cells
Specific factors to consider when using red cells
Use of Group O Rh(D)-negative red cells
Use of platelets
Use of fresh frozen plasma
Use of cryodepleted plasma
Use of cryoprecipitate
Use of whole blood
Informed consent
Patient identification
Documentation & traceability
Requests for transfusions
Blood collection & delivery
Pretransfusion blood samples
Compatibility testing
Administration of blood components
Monitoring & observation
Patient Blood Management
Patient Blood Management Guidelines
Anaemia & haemostasis management
Iron deficiency anaemia
Risk groups and causes
IDA clinical consequences
Iron deficiency without anaemia
Anaemia in blood donors
Donor Hb & iron assessment
Donors with low Hb
Diagnosis and investigation
Initial tests
Additional tests
Lab results interpretation
Management of IDA
Treatment of IDA
Oral preparations for IDA treatment
Inadequate response
Medication and food interactions
Side effects
Intravenous iron
Underlying causes
Bleeding disorders
Disseminated intravascular coagulation
Management of DIC
Haemorrhage
Massive transfusion
Therapy indications in massive transfusion
Thrombocytopaenia
Warfarin reversal
Management of an elevated INR
Guidelines for managing an elevated INR in adults
Interrupting warfarin therapy
Thrombocytopenic purpura
Obstetric transfusion
Fetomaternal conditions
Haemolytic disease of the newborn
Neonatal Alloimmune Thrombocytopaenia
Pregnancy and Anti-D
Guidelines for using Rh(D) immunoglobulin
Blood conservation
Requirements for autologous blood
Risks & adverse events
Haemovigilance
Transfusion risks
Risk estimates for transmitted infections
FAQ: Risk estimates of transmitted infections
TTI surveillance in Australia
Transfusion adverse reactions
Allergic reaction
Anaphylaxis
Febrile non-haemolytic reactions
Haemolysis
Infectious reactions
Iron overload
Metabolic complications
Post-transfusion purpura
TAGVHD
TRALI
Circulatory overload
Management of suspected reactions
Supply & Demand
National Inventory Template
FAQ: National Inventory Template
National Blood Supply Contingency Plan
NBSCP: Laboratory Perspective
Monitoring wastage
How to monitor wastage
Quarantine
Non-conforming products
Short date products
Emergency or low stock
Maximum Blood Order Schedules
Issuable stock index
Emergency donor panels
News, events & library
Transfusion Update
TU12
TU11
TU10
TU09
TU08
iTransfuse express news
e-News archive
Presentations
Fact sheets
Podcasts
Photo gallery
Library
Request & order forms
Research & registries
Australian Blood Organisations
Interesting reading
iTransfuse Online Learning
iTransfuse Online for beginners
iOL Terms of use
Mobile apps
ERIC
Transplantation Services
Home
The Transfusion Site Map
Front page
Front page of
Transfusion Medicine Service
Footer Links
Disclaimer
Privacy policy
Staff webmail
Header Links
iTransfuse Online Learning
About us
Authors & editors
Dr Ben Saxon
Dr Beverleigh Quested
Dr Cindy Flores
Dr Clive Seed
Dr Kathryn Robinson
Dr Kenneth Nollet
Dr Keri Hughes
Dr Oi-Lin Lee
Dr Sandy Minck
Jenita Allen
Simon Benson
Tanya Raison
Tracey Spigiel
Medical Services
Contact us
Inventory & distribution
Feedback form
iTransfuse Online Learning Support
Site map
Primary links
Blood products
Blood components
Red cells
Red cell additives
Platelets
Platelet additives
Apheresis platelet packs
Fresh frozen plasma
Apheresis plasma packs
Cryodepleted plasma
Cryoprecipitate
Whole blood
Whole blood anticoagulants
Modified blood components
CMV seronegative
CMV tested components
Frozen Red cells
Irradiation
Indications for irradiated components
Paediatric size
Phenotyped
Washed
FAQ: Leucodepletion
Fractionated plasma products
Albumin
Factor concentrates
Immunoglobulins
Intravenous immunoglobulin
IVIg calculator
Component labelling
Label modifier texts
Donor selection
Collection & testing
Bacterial contamination screening
Screening platelets for contamination
Pathogen inactivation
FAQ: NAT for HBV
Therapeutic venesection
Blood groups
Blood group phenotypes
Rhesus phenotypes
Inheritance patterns
Antigens & antibodies
Red cell antigens
Platelet antigens
Neutrophil antigens
Leucocyte antigens
Compatibility
Red cell compatibility
Platelet compatibility
Plasma compatibility
Storage & handling
Transport of blood
Validated transport times
Maintenance of storage devices
Transfusion practice
Overview of transfusion medicine
Does your patient need a transfusion?
Minimise the need for a transfusion
Transfusion alternatives
Plasma replacement fluids
Indications for recombinant products
Checklist for prescribing clinicians
Transfusion committees
How to start a HTC
Clinical governance
Appropriate transfusion practices
Clinical use of blood components
Use of red cells
Specific factors to consider when using red cells
Use of Group O Rh(D)-negative red cells
Use of platelets
Use of fresh frozen plasma
Use of cryodepleted plasma
Use of cryoprecipitate
Use of whole blood
Informed consent
Patient identification
Documentation & traceability
Requests for transfusions
Blood collection & delivery
Pretransfusion blood samples
Compatibility testing
Administration of blood components
Monitoring & observation
Patient Blood Management
Patient Blood Management Guidelines
Anaemia & haemostasis management
Iron deficiency anaemia
Risk groups and causes
IDA clinical consequences
Iron deficiency without anaemia
Anaemia in blood donors
Donor Hb & iron assessment
Donors with low Hb
Diagnosis and investigation
Initial tests
Additional tests
Lab results interpretation
Management of IDA
Treatment of IDA
Oral preparations for IDA treatment
Inadequate response
Medication and food interactions
Side effects
Intravenous iron
Underlying causes
Bleeding disorders
Disseminated intravascular coagulation
Management of DIC
Haemorrhage
Massive transfusion
Therapy indications in massive transfusion
Thrombocytopaenia
Warfarin reversal
Management of an elevated INR
Guidelines for managing an elevated INR in adults
Interrupting warfarin therapy
Thrombocytopenic purpura
Obstetric transfusion
Fetomaternal conditions
Haemolytic disease of the newborn
Neonatal Alloimmune Thrombocytopaenia
Pregnancy and Anti-D
Guidelines for using Rh(D) immunoglobulin
Blood conservation
Requirements for autologous blood
Risks & adverse events
Haemovigilance
Transfusion risks
Risk estimates for transmitted infections
FAQ: Risk estimates of transmitted infections
TTI surveillance in Australia
Transfusion adverse reactions
Allergic reaction
Anaphylaxis
Febrile non-haemolytic reactions
Haemolysis
Infectious reactions
Iron overload
Metabolic complications
Post-transfusion purpura
TAGVHD
TRALI
Circulatory overload
Management of suspected reactions
Supply & Demand
National Inventory Template
FAQ: National Inventory Template
National Blood Supply Contingency Plan
NBSCP: Laboratory Perspective
Monitoring wastage
How to monitor wastage
Quarantine
Non-conforming products
Short date products
Emergency or low stock
Maximum Blood Order Schedules
Issuable stock index
Emergency donor panels
News, events & library
Transfusion Update
TU12
TU11
TU10
TU09
TU08
iTransfuse express news
e-News archive
Presentations
Fact sheets
Podcasts
Photo gallery
Library
Request & order forms
Research & registries
Australian Blood Organisations
Interesting reading
iTransfuse Online Learning
iTransfuse Online for beginners
iOL Terms of use
Mobile apps
ERIC
Transplantation Services
This site complies with the HONcode standard for trustworthy health information: verify here. This site complies with the HONcode standard for trustworthy health information: verify here.